市場調査レポート

商品コード

1269398

医療用食品市場（製品タイプ：錠剤、粉末、液体、その他、投与経路：経口、経腸）-世界の産業分析、規模、シェア、成長、動向、予測、2023年-2031年

Medical Foods Market (Product Type: Pills, Powder, Liquid, and Others; Route of Administration: Oral and Enteral) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

出版日: 2023年03月14日 | 発行: Transparency Market Research

| ページ情報: 英文 232 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF (Single User License)

USD 5,795 907,091円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は可能です。印刷物の取り扱いは電子版のライセンス範囲に準拠します。

PDF (Multi-user License)

USD 8,795 1,376,681円

レポートPDFを同一の部署内・課内の方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は可能です。印刷物の取り扱いは電子版のライセンス範囲に準拠します。

PDF (Corporate License)

USD 11,795 1,846,271円

レポートPDFを企業内すべての方に使用頂けるライセンスです。ご利用人数の制限はありません。 PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は可能です。印刷物の取り扱いは電子版のライセンス範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.53円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

医療用食品市場- 調査範囲：

TMRの調査レポート「世界の医療用食品市場」は、2023年から2031年までの予測期間における市場の指標について貴重な洞察を得るために、過去だけでなく現在の成長動向と機会も調査しています。本レポートでは、2023年を基準年、2031年を予測年として、2017年から2031年までの期間における世界の医療用食品市場の収益を提供します。また、2023年から2031年までの世界の医療用食品市場のCAGRを掲載しています。

本レポートは、広範な調査を経て作成されました。1次調査では、アナリストが主要オピニオンリーダー、業界リーダー、オピニオンメーカーへのインタビューを実施し、調査作業の大部分を行っています。2次調査では、主要企業の製品資料、年次報告書、プレスリリース、関連文書などを参照し、医療用食品市場を把握しました。

本レポートは、世界の医療用食品市場の競合情勢を掘り下げています。世界の医療用食品市場で事業を展開する主要企業が特定され、それぞれの企業が様々な属性でプロファイリングされています。企業概要、財務状況、最近の市場開拓、SWOTは、本レポートで紹介されている世界の医療食品市場のプレイヤーの属性です。

イントロダクションと定義
主な調査結果／発展状況
市場価値予測：疾患タイプ別、2017-2031年
- オーファン疾患
  - デュシェンヌ型筋ジストロフィー（DMD）
  - 鎌状赤血球貧血
  - 血友病
  - その他
- がん
- 神経・精神疾患
- 代謝性疾患
- 疼痛管理
- 消化器系疾患
- 眼科領域
- 糖尿病
- フェニルケトン尿症（PKU）
- てんかん
市場魅力分析：疾患タイプ別

第8章世界市場分析・予測：投与経路別

イントロダクションと定義
主な調査結果/発展状況
市場価値予測：投与経路別、2017年～2031年
- 経口
- 経腸
市場魅力分析：投与経路別

第9章世界市場分析・予測：流通チャネル別

イントロダクションと定義
主な調査結果/発展状況
市場価値予測：流通チャネル別、2017-2031年
- 薬局・ドラッグストア
- オンラインチャネル
- スーパーマーケット＆ハイパーマーケット
- その他
市場魅力分析：流通チャネル別

第10章世界市場分析・予測：地域別

主な調査結果
市場規模予測：地域別
- 北米
- 欧州
- アジア太平洋
- ラテンアメリカ
- 中東・アフリカ地域
市場魅力分析：地域別

第11章北米市場の分析・予測

イントロダクション
- 主な調査結果
市場価値予測：製品タイプ別、2017-2031年
- 錠剤
- 粉末
- 液体
- その他
市場価値予測：疾患タイプ別、2017-2031年
- オーファン疾患
  - デュシェンヌ型筋ジストロフィー（DMD）
  - 鎌状赤血球貧血
  - 血友病
  - その他
- がん
- 神経・精神疾患
- 代謝性疾患
- 疼痛管理
- 消化器系疾患
- 眼科領域
- 糖尿病
- フェニルケトン尿症（PKU）
- てんかん
市場価値予測：投与経路別、2017-2031年
- 経口
- 経腸
市場価値予測：流通チャネル別、2017-2031年
- 薬局・ドラッグストア
- オンラインチャネル
- スーパーマーケット＆ハイパーマーケット
- その他
市場価値予測：国別、2017-2031年
- 米国
- カナダ
市場の魅力分析
- 製品別
- 疾患タイプ別
- 投与経路別
- 販売チャネル別
- 国別

第12章欧州市場の分析と予測

イントロダクション
- 主要な調査結果
市場価値予測：製品タイプ別、2017-2031年
- 錠剤
- 粉末
- 液体
- その他
市場価値予測：疾患タイプ別、2017-2031年
- オーファン疾患
  - デュシェンヌ型筋ジストロフィー（DMD）
  - 鎌状赤血球貧血
  - 血友病
  - その他
- がん
- 神経・精神疾患
- 代謝性疾患
- 疼痛管理
- 消化器系疾患
- 眼科領域
- 糖尿病
- フェニルケトン尿症（PKU）
- てんかん
市場価値予測：投与経路別、2017-2031年
- 経口
- 経腸
市場価値予測：流通チャネル別、2017-2031年
- 薬局・ドラッグストア
- オンラインチャネル
- スーパーマーケット＆ハイパーマーケット
- その他
市場価値予測：国・小地域別、2017-2031年
- ドイツ
- 英国
- フランス
- スペイン
- イタリア
- その他欧州
市場魅力分析
- 製品タイプ別
- 疾患タイプ別
- 投与経路別
- 販売チャネル別
- 国別／サブリージョン別

第13章アジア太平洋地域の市場分析と予測

イントロダクション
- 主な調査結果
市場価値予測：製品タイプ別、2017-2031年
- 錠剤
- 粉末
- 液体
- その他
市場価値予測：疾患タイプ別、2017-2031年
- オーファン疾患
  - デュシェンヌ型筋ジストロフィー（DMD）
  - 鎌状赤血球貧血
  - 血友病
  - その他
- がん
- 神経・精神疾患
- 代謝性疾患
- 疼痛管理
- 消化器系疾患
- 眼科領域
- 糖尿病
- フェニルケトン尿症（PKU）
- てんかん
市場価値予測：投与経路別、2017-2031年
- 経口剤
- 経腸
市場価値予測：流通チャネル別、2017-2031年
- 薬局・ドラッグストア
- オンラインチャネル
- スーパーマーケット＆ハイパーマーケット
- その他
市場価値予測：国・小地域別、2017-2031年
- 中国
- 日本
- インド
- オーストラリア・ニュージーランド
- その他アジア太平洋地域
市場の魅力分析
- 製品タイプ別
- 疾患タイプ別
- 投与経路別
- 販売チャネル別
- 国別／サブリージョン別

第14章ラテンアメリカの市場分析・予測

イントロダクション
- 主要な調査結果
市場価値予測：製品タイプ別、2017年～2031年
- 錠剤
- 粉末
- 液体
- その他
市場価値予測：疾患タイプ別、2017-2031年
- オーファン疾患
  - デュシェンヌ型筋ジストロフィー（DMD）
  - 鎌状赤血球貧血
  - 血友病
  - その他
- がん
- 神経・精神疾患
- 代謝性疾患
- 疼痛管理
- 消化器系疾患
- 眼科領域
- 糖尿病
- フェニルケトン尿症（PKU）
- てんかん
市場価値予測：投与経路別、2017-2031年
- 経口剤
- 経腸
市場価値予測：流通チャネル別、2017-2031年
- 薬局・ドラッグストア
- オンラインチャネル
- スーパーマーケット＆ハイパーマーケット
- その他
市場価値予測：国・小地域別、2017-2031年
- ブラジル
- メキシコ
- その他ラテンアメリカ地域
市場魅力分析
- 製品タイプ別
- 疾患タイプ別
- 投与経路別
- 販売チャネル別
- 国別／サブリージョン別

第15章中東・アフリカ市場の分析と予測

イントロダクション
- 主な調査結果
市場価値予測：製品タイプ別、2017年～2031年
- 錠剤
- 粉末
- 液体
- その他
市場価値予測：疾患タイプ別、2017-2031年
- オーファン疾患
  - デュシェンヌ型筋ジストロフィー（DMD）
  - 鎌状赤血球貧血
  - 血友病
  - その他
- がん
- 神経・精神疾患
- 代謝性疾患
- 疼痛管理
- 消化器系疾患
- 眼科領域
- 糖尿病
- フェニルケトン尿症（PKU）
- てんかん
市場価値予測：投与経路別、2017-2031年
- 経口
- 経腸
市場価値予測：流通チャネル別、2017-2031年
- 薬局・ドラッグストア
- オンラインチャネル
- スーパーマーケット＆ハイパーマーケット
- その他
市場価値予測：国・小地域別、2017-2031年
- GCC諸国
- 南アフリカ
- その他中東・アフリカ
市場の魅力分析
- 製品タイプ別
- 疾患タイプ別
- 投与経路別
- 販売チャネル別
- 国別／サブリージョン別

第16章競合情勢

市場競合-競争マトリックス（企業階層別、企業規模別）
競合のビジネス戦略
企業プロファイル
- Nutricia（Danone）
- Nestle S.A.
- Abbott Laboratories
- Mead Johnson Nutrition
- Fresenius Kabi
- Friso
- Morinaga Milk Industry
- Primus Pharmaceuticals, Inc.
- Targeted Medical Pharma, Inc.
- Medtrition, Inc.

図表

List of Tables

Table 01: Global Medical Foods Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
Table 02: Global Medical Foods Market Value (US$ Mn) Forecast, by Disease Type, 2017-2031
Table 03: Global Medical Foods Market Value (US$ Mn) Forecast, by Orphan Disease, 2017-2031
Table 04: Global Medical Foods Market Value (US$ Mn) Forecast, by Route of Administration, 2017-2031
Table 05: Global Medical Foods Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
Table 06: Global Medical Foods Market Value (US$ Mn) Forecast, by Country, 2017-2031
Table 07: Europe Medical Foods Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 08: Europe Medical Foods Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
Table 09: Europe Medical Foods Market Value (US$ Mn) Forecast, by Disease Type, 2017-2031
Table 10: Europe Medical Foods Market Value (US$ Mn) Forecast, by Orphan Disease, 2017-2031
Table 11: Europe Medical Foods Market Value (US$ Mn) Forecast, by Route of Administration, 2017-2031
Table 12: Europe Medical Foods Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
Table 13: North America Medical Foods Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
Table 14: North America Medical Foods Market Value (US$ Mn) Forecast, by Disease Type, 2017-2031
Table 15: North America Medical Foods Market Value (US$ Mn) Forecast, by Orphan Disease, 2017-2031
Table 16: North America Medical Foods Market Value (US$ Mn) Forecast, by Route of Administration, 2017-2031
Table 17: North America Medical Foods Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
Table 18: Asia Pacific Medical Foods Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
Table 19: Asia Pacific Medical Foods Market Value (US$ Mn) Forecast, by Disease Type, 2017-2031
Table 20: Asia Pacific Medical Foods Market Value (US$ Mn) Forecast, by Orphan Disease, 2017-2031
Table 21: Asia Pacific Medical Foods Market Value (US$ Mn) Forecast, by Route of Administration, 2017-2031
Table 22: Asia Pacific Medical Foods Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
Table 23: Latin America Medical Foods Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
Table 24: Latin America Medical Foods Market Value (US$ Mn) Forecast, by Disease Type, 2017-2031
Table 25: Latin America Medical Foods Market Value (US$ Mn) Forecast, by Orphan Disease, 2017-2031
Table 26: Latin America Medical Foods Market Value (US$ Mn) Forecast, by Route of Administration, 2017-2031
Table 27: Latin America Medical Foods Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
Table 28: Middle East and Africa Medical Foods Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
Table 29: Middle East and Africa Medical Foods Market Value (US$ Mn) Forecast, by Disease Type, 2017-2031
Table 30: Middle East and Africa Medical Foods Market Value (US$ Mn) Forecast, by Orphan Disease, 2017-2031
Table 31: Middle East and Africa Medical Foods Market Value (US$ Mn) Forecast, by Route of Administration, 2017-2031
Table 32: Middle East and Africa Medical Foods Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031

List of Figures

Figure 01: Global Medical Foods Market Value Share Analysis, by Product Type, 2022 and 2031
Figure 02: Global Medical Foods Market Attractiveness Analysis, by Product Type, 2023-2031
Figure 03: Global Medical Foods Market Revenue (US$ Mn), by Pills, 2017-2031
Figure 04: Global Medical Foods Market Revenue (US$ Mn), by Powder, 2017-2031
Figure 05: Global Medical Foods Market Revenue (US$ Mn), by Liquid, 2017-2031
Figure 06: Global Medical Foods Market Revenue (US$ Mn), by Others, 2017-2031
Figure 07: Global Medical Foods Market Value Share Analysis, by Disease Type, 2022 and 2031
Figure 08: Global Medical Foods Market Attractiveness Analysis, by Disease Type, 2023-2031
Figure 09: Global Medical Foods Market Revenue (US$ Mn), by Orphan Disease, 2017-2031
Figure 10: Global Medical Foods Market Revenue (US$ Mn), by Cancer, 2017-2031
Figure 11: Global Medical Foods Market Revenue (US$ Mn), by Neurological & Psychological Disorders, 2017-2031
Figure 12: Global Medical Foods Market Revenue (US$ Mn), by Metabolic Disorders, 2017-2031
Figure 13: Global Medical Foods Market Revenue (US$ Mn), by Pain Management, 2017-2031
Figure 14: Global Medical Foods Market Revenue (US$ Mn), by Gastrointestinal Disorders, 2017-2031
Figure 15: Global Medical Foods Market Revenue (US$ Mn), by Ophthalmology, 2017-2031
Figure 16 Global Medical Foods Market Revenue (US$ Mn), by Diabetes, 2017-2031
Figure 17: Global Medical Foods Market Revenue (US$ Mn), by Phenylketonuria (PKU), 2017-2031
Figure 18: Global Medical Foods Market Revenue (US$ Mn), by Epilepsy, 2017-2031
Figure 19: Global Medical Foods Market Value Share Analysis, by Route of Administration, 2022 and 2031
Figure 20: Global Medical Foods Market Attractiveness Analysis, by Route of Administration, 2023-2031
Figure 21: Global Medical Foods Market Revenue (US$ Mn), by Oral, 2017-2031
Figure 22: Global Medical Foods Market Revenue (US$ Mn), by Enteral, 2017-2031
Figure 23: Global Medical Foods Market Value Share Analysis, by Distribution Channel, 2022 and 2031
Figure 24: Global Medical Foods Market Attractiveness Analysis, by Distribution Channel, 2023-2031
Figure 25: Global Medical Foods Market Revenue (US$ Mn), by Pharmacies & Drug Stores, 2017-2031
Figure 26: Global Medical Foods Market Revenue (US$ Mn), by Online Channels, 2017-2031
Figure 27: Global Medical Foods Market Revenue (US$ Mn), by Supermarkets & Hypermarkets, 2017-2031
Figure 28: Global Medical Foods Market Revenue (US$ Mn), by Others, 2017-2031
Figure 29: Global Medical Foods Market Value Share Analysis, by Country, 2022 and 2031
Figure 30: Global Medical Foods Market Attractiveness Analysis, by Country, 2023-2031
Figure 31: North America Medical Foods Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 32: North America Medical Foods Market Value Share Analysis, by Product Type, 2022 and 2031
Figure 33: North America Medical Foods Market Attractiveness Analysis, by Product Type, 2023-2031
Figure 34: North America Medical Foods Market Value Share Analysis, by Disease Type, 2022 and 2031
Figure 35 North America Medical Foods Market Attractiveness Analysis, by Disease Type, 2023-2031
Figure 36: North America Medical Foods Market Value Share Analysis, by Route of Administration, 2021 and 2031
Figure 37: North America Medical Foods Market Attractiveness Analysis, by Route of Administration, 2022-2031
Figure 38: North America Medical Foods Market Value Share Analysis, by Distribution Channel, 2021 and 2031
Figure 39: North America Medical Foods Market Attractiveness Analysis, by Distribution Channel, 2022-2031
Figure 40: Europe Medical Foods Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 41: Europe Medical Foods Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 42: Europe Medical Foods Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 43: Europe Medical Foods Market Value Share Analysis, by Product Type, 2022 and 2031
Figure 44: Europe Medical Foods Market Attractiveness Analysis, by Product Type, 2023-2031
Figure 45: Europe Medical Foods Market Value Share Analysis, by Disease Type, 2022 and 2031
Figure 46: Europe Medical Foods Market Attractiveness Analysis, by Disease Type, 2023-2031
Figure 47: Europe Medical Foods Market Value Share Analysis, by Route of Administration, 2021 and 2031
Figure 48: Europe Medical Foods Market Attractiveness Analysis, by Route of Administration, 2022-2031
Figure 49: Europe Medical Foods Market Value Share Analysis, by Distribution Channel, 2021 and 2031
Figure 50: Europe Medical Foods Market Attractiveness Analysis, by Distribution Channel, 2022-2031
Figure 51: Asia Pacific Medical Foods Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 52: Asia Pacific Medical Foods Market Value Share Analysis, by Product Type, 2022 and 2031
Figure 53: Asia Pacific Medical Foods Market Attractiveness Analysis, by Product Type, 2023-2031
Figure 54: Asia Pacific Medical Foods Market Value Share Analysis, by Disease Type, 2022 and 2031
Figure 55: Asia Pacific Medical Foods Market Attractiveness Analysis, by Disease Type, 2023-2031
Figure 56: Asia Pacific Medical Foods Market Value Share Analysis, by Route of Administration, 2021 and 2031
Figure 57: Asia Pacific Medical Foods Market Attractiveness Analysis, by Route of Administration, 2022-2031
Figure 58: Asia Pacific Medical Foods Market Value Share Analysis, by Distribution Channel, 2021 and 2031
Figure 59: Asia Pacific Medical Foods Market Attractiveness Analysis, by Distribution Channel, 2022-2031
Figure 60: Latin America Medical Foods Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 61: Latin America Medical Foods Market Value Share Analysis, by Product Type, 2022 and 2031
Figure 62: Latin America Medical Foods Market Attractiveness Analysis, by Product Type, 2023-2031
Figure 63: Latin America Medical Foods Market Value Share Analysis, by Disease Type, 2022 and 2031
Figure 64: Latin America Medical Foods Market Attractiveness Analysis, by Disease Type, 2023-2031
Figure 65: Latin America Medical Foods Market Value Share Analysis, by Route of Administration, 2021 and 2031
Figure 66: Latin America Medical Foods Market Attractiveness Analysis, by Route of Administration, 2022-2031
Figure 67: Latin America Medical Foods Market Value Share Analysis, by Distribution Channel, 2021 and 2031
Figure 68: Latin America Medical Foods Market Attractiveness Analysis, by Distribution Channel, 2022-2031
Figure 69: Middle East and Africa Medical Foods Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 70: Middle East and Africa Medical Foods Market Value Share Analysis, by Product Type, 2022 and 2031
Figure 71: Middle East and Africa Medical Foods Market Attractiveness Analysis, by Product Type, 2023-2031
Figure 72: Middle East and Africa Medical Foods Market Value Share Analysis, by Disease Type, 2022 and 2031
Figure 73: Middle East and Africa Medical Foods Market Attractiveness Analysis, by Disease Type, 2023-2031
Figure 74: Middle East and Africa Medical Foods Market Value Share Analysis, by Route of Administration, 2021 and 2031
Figure 75: Middle East and Africa Medical Foods Market Attractiveness Analysis, by Route of Administration, 2022-2031
Figure 76: Middle East and Africa Medical Foods Market Value Share Analysis, by Distribution Channel, 2021 and 2031
Figure 77: Middle East and Africa Medical Foods Market Attractiveness Analysis, by Distribution Channel, 2022-2031

Product Code: TMRGL45447

Medical Foods Market - Scope of Report:

TMR's report on the global medical foods market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global medical foods market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global medical foods market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the medical foods market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global medical foods market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global medical foods market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global medical foods market.

The report delves into the competitive landscape of the global medical foods market. Key players operating in the global medical foods market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global medical foods market profiled in this report.

Key Questions Answered in Global Medical Foods Market Report:

What is the sales/revenue generated by medical foods across all regions during the forecast period?

What are the opportunities in the global medical foods market?

What are the major drivers, restraints, opportunities, and threats in the market?

Which regional market is set to expand at the fastest CAGR during the forecast period?

Which segment is expected to generate the highest revenue globally in 2031?

Which segment is projected to expand at the highest CAGR during the forecast period?

What are the market positions of different companies operating in the global market?

Medical Foods Market - Research Objectives and Research Approach:

The comprehensive report on the global medical foods market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global medical foods market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global medical foods market.

1. Preface

1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Medical Foods Market

4. Market Overview

4.1. Introduction
4.2. Overview
4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities

5. Key Insights

5.1. Important market developments
5.2. Top 3 Players Operating in the Market Space
5.3. New competitive market entrants
5.4. Medical food regulation overview
5.5. Reimbursement Scenario
5.6. Overview of the Distribution Channel of Medical Foods in various diseases along with examples

6. Global Medical Foods Market Analysis and Forecast, by Product Type

6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product Type, 2017-2031
- 6.3.1. Pills
- 6.3.2. Powder
- 6.3.3. Liquid
- 6.3.4. Others
6.4. Market Attractiveness Analysis, by Product Type

7. Global Medical Foods Market Analysis and Forecast, by Disease Type

7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Disease Type, 2017-2031
- 7.3.1. Orphan Disease
  - 7.3.1.1. Duchenne Muscular Dystrophy (DMD)
  - 7.3.1.2. Sickle Cell Anemia
  - 7.3.1.3. Hemophilia
  - 7.3.1.4. Others
- 7.3.2. Cancer
- 7.3.3. Neurological & Psychological Disorders
- 7.3.4. Metabolic Disorders
- 7.3.5. Pain Management
- 7.3.6. Gastrointestinal Disorders
- 7.3.7. Ophthalmology
- 7.3.8. Diabetes
- 7.3.9. Phenylketonuria (PKU)
- 7.3.10. Epilepsy
7.4. Market Attractiveness Analysis, by Disease Type

8. Global Medical Foods Market Analysis and Forecast, by Route of Administration

8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Route of Administration, 2017-2031
- 8.3.1. Oral
- 8.3.2. Enteral
8.4. Market Attractiveness Analysis, by Route of Administration

9. Global Medical Foods Market Analysis and Forecast, by Distribution Channel

9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Market Value Forecast, by Distribution Channel, 2017-2031
- 9.3.1. Pharmacies & Drug Stores
- 9.3.2. Online Channels
- 9.3.3. Supermarkets & Hypermarkets
- 9.3.4. Others
9.4. Market Attractiveness Analysis, by Distribution Channel

10. Global Medical Foods Market Analysis and Forecast, by Region

10.1. Key Findings
10.2. Market Value Forecast, by Region
- 10.2.1. North America
- 10.2.2. Europe
- 10.2.3. Asia Pacific
- 10.2.4. Latin America
- 10.2.5. Middle East & Africa
10.3. Market Attractiveness Analysis, by Region

11. North America Medical Foods Market Analysis and Forecast

11.1. Introduction
- 11.1.1. Key Findings
11.2. Market Value Forecast, by Product Type, 2017-2031
- 11.2.1. Pills
- 11.2.2. Powder
- 11.2.3. Liquid
- 11.2.4. Others
11.3. Market Value Forecast, by Disease Type, 2017-2031
- 11.3.1. Orphan Disease
  - 11.3.1.1. Duchenne Muscular Dystrophy (DMD)
  - 11.3.1.2. Sickle Cell Anemia
  - 11.3.1.3. Hemophilia
  - 11.3.1.4. Others
- 11.3.2. Cancer
- 11.3.3. Neurological & Psychological Disorders
- 11.3.4. Metabolic Disorders
- 11.3.5. Pain Management
- 11.3.6. Gastrointestinal Disorders
- 11.3.7. Ophthalmology
- 11.3.8. Diabetes
- 11.3.9. Phenylketonuria (PKU)
- 11.3.10. Epilepsy
11.4. Market Value Forecast, by Route of Administration, 2017-2031
- 11.4.1. Oral
- 11.4.2. Enteral
11.5. Market Value Forecast, by Distribution Channel, 2017-2031
- 11.5.1. Pharmacies & Drug Stores
- 11.5.2. Online Channels
- 11.5.3. Supermarkets & Hypermarkets
- 11.5.4. Others
11.6. Market Value Forecast, by Country, 2017-2031
- 11.6.1. U.S.
- 11.6.2. Canada
11.7. Market Attractiveness Analysis
- 11.7.1. By Product
- 11.7.2. By Disease Type
- 11.7.3. By Route of Administration
- 11.7.4. By Distribution Channel
- 11.7.5. By Country

12. Europe Medical Foods Market Analysis and Forecast

12.1. Introduction
- 12.1.1. Key Findings
12.2. Market Value Forecast, by Product Type, 2017-2031
- 12.2.1. Pills
- 12.2.2. Powder
- 12.2.3. Liquid
- 12.2.4. Others
12.3. Market Value Forecast, by Disease Type, 2017-2031
- 12.3.1. Orphan Disease
  - 12.3.1.1. Duchenne Muscular Dystrophy (DMD)
  - 12.3.1.2. Sickle Cell Anemia
  - 12.3.1.3. Hemophilia
  - 12.3.1.4. Others
- 12.3.2. Cancer
- 12.3.3. Neurological & Psychological Disorders
- 12.3.4. Metabolic Disorders
- 12.3.5. Pain Management
- 12.3.6. Gastrointestinal Disorders
- 12.3.7. Ophthalmology
- 12.3.8. Diabetes
- 12.3.9. Phenylketonuria (PKU)
- 12.3.10. Epilepsy
12.4. Market Value Forecast, by Route of Administration, 2017-2031
- 12.4.1. Oral
- 12.4.2. Enteral
12.5. Market Value Forecast, by Distribution Channel, 2017-2031
- 12.5.1. Pharmacies & Drug Stores
- 12.5.2. Online Channels
- 12.5.3. Supermarkets & Hypermarkets
- 12.5.4. Others
12.6. Market Value Forecast, by Country/Sub-region, 2017-2031
- 12.6.1. Germany
- 12.6.2. U.K.
- 12.6.3. France
- 12.6.4. Spain
- 12.6.5. Italy
- 12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
- 12.7.1. by Product Type
- 12.7.2. By Disease Type
- 12.7.3. By Route of Administration
- 12.7.4. By Distribution Channel
- 12.7.5. By Country/Sub-region

13. Asia Pacific Medical Foods Market Analysis and Forecast

13.1. Introduction
- 13.1.1. Key Findings
13.2. Market Value Forecast, by Product Type, 2017-2031
- 13.2.1. Pills
- 13.2.2. Powder
- 13.2.3. Liquid
- 13.2.4. Others
13.3. Market Value Forecast, by Disease Type, 2017-2031
- 13.3.1. Orphan Disease
  - 13.3.1.1. Duchenne Muscular Dystrophy (DMD)
  - 13.3.1.2. Sickle Cell Anemia
  - 13.3.1.3. Hemophilia
  - 13.3.1.4. Others
- 13.3.2. Cancer
- 13.3.3. Neurological & Psychological Disorders
- 13.3.4. Metabolic Disorders
- 13.3.5. Pain Management
- 13.3.6. Gastrointestinal Disorders
- 13.3.7. Ophthalmology
- 13.3.8. Diabetes
- 13.3.9. Phenylketonuria (PKU)
- 13.3.10. Epilepsy
13.4. Market Value Forecast, by Route of Administration, 2017-2031
- 13.4.1. Oral
- 13.4.2. Enteral
13.5. Market Value Forecast, by Distribution Channel, 2017-2031
- 13.5.1. Pharmacies & Drug Stores
- 13.5.2. Online Channels
- 13.5.3. Supermarkets & Hypermarkets
- 13.5.4. Others
13.6. Market Value Forecast, by Country/Sub-region, 2017-2031
- 13.6.1. China
- 13.6.2. Japan
- 13.6.3. India
- 13.6.4. Australia & New Zealand
- 13.6.5. Rest of Asia Pacific
13.7. Market Attractiveness Analysis
- 13.7.1. by Product Type
- 13.7.2. By Disease Type
- 13.7.3. By Route of Administration
- 13.7.4. By Distribution Channel
- 13.7.5. By Country/Sub-region

14. Latin America Medical Foods Market Analysis and Forecast

14.1. Introduction
- 14.1.1. Key Findings
14.2. Market Value Forecast, by Product Type, 2017-2031
- 14.2.1. Pills
- 14.2.2. Powder
- 14.2.3. Liquid
- 14.2.4. Others
14.3. Market Value Forecast, by Disease Type, 2017-2031
- 14.3.1. Orphan Disease
  - 14.3.1.1. Duchenne Muscular Dystrophy (DMD)
  - 14.3.1.2. Sickle Cell Anemia
  - 14.3.1.3. Hemophilia
  - 14.3.1.4. Others
- 14.3.2. Cancer
- 14.3.3. Neurological & Psychological Disorders
- 14.3.4. Metabolic Disorders
- 14.3.5. Pain Management
- 14.3.6. Gastrointestinal Disorders
- 14.3.7. Ophthalmology
- 14.3.8. Diabetes
- 14.3.9. Phenylketonuria (PKU)
- 14.3.10. Epilepsy
14.4. Market Value Forecast, by Route of Administration, 2017-2031
- 14.4.1. Oral
- 14.4.2. Enteral
14.5. Market Value Forecast, by Distribution Channel, 2017-2031
- 14.5.1. Pharmacies & Drug Stores
- 14.5.2. Online Channels
- 14.5.3. Supermarkets & Hypermarkets
- 14.5.4. Others
14.6. Market Value Forecast, by Country/Sub-region, 2017-2031
- 14.6.1. Brazil
- 14.6.2. Mexico
- 14.6.3. Rest of Latin America
14.7. Market Attractiveness Analysis
- 14.7.1. by Product Type
- 14.7.2. By Disease Type
- 14.7.3. By Route of Administration
- 14.7.4. By Distribution Channel
- 14.7.5. By Country/Sub-region

15. Middle East & Africa Medical Foods Market Analysis and Forecast

15.1. Introduction
- 15.1.1. Key Findings
15.2. Market Value Forecast, by Product Type, 2017-2031
- 15.2.1. Pills
- 15.2.2. Powder
- 15.2.3. Liquid
- 15.2.4. Others
15.3. Market Value Forecast, by Disease Type, 2017-2031
- 15.3.1. Orphan Disease
  - 15.3.1.1. Duchenne Muscular Dystrophy (DMD)
  - 15.3.1.2. Sickle Cell Anemia
  - 15.3.1.3. Hemophilia
  - 15.3.1.4. Others
- 15.3.2. Cancer
- 15.3.3. Neurological & Psychological Disorders
- 15.3.4. Metabolic Disorders
- 15.3.5. Pain Management
- 15.3.6. Gastrointestinal Disorders
- 15.3.7. Ophthalmology
- 15.3.8. Diabetes
- 15.3.9. Phenylketonuria (PKU)
- 15.3.10. Epilepsy
15.4. Market Value Forecast, by Route of Administration, 2017-2031
- 15.4.1. Oral
- 15.4.2. Enteral
15.5. Market Value Forecast, by Distribution Channel, 2017-2031
- 15.5.1. Pharmacies & Drug Stores
- 15.5.2. Online Channels
- 15.5.3. Supermarkets & Hypermarkets
- 15.5.4. Others
15.6. Market Value Forecast, by Country/Sub-region, 2017-2031
- 15.6.1. GCC Countries
- 15.6.2. South Africa
- 15.6.3. Rest of Middle East & Africa
15.7. Market Attractiveness Analysis
- 15.7.1. by Product Type
- 15.7.2. By Disease Type
- 15.7.3. By Route of Administration
- 15.7.4. By Distribution Channel
- 15.7.5. By Country/Sub-region

16. Competition Landscape

16.1. Market Player - Competition Matrix (by tier and size of companies)
16.2. Competitive Business Strategies
16.3. Company Profiles
- 16.3.1. Nutricia (Danone)
  - 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 16.3.1.2. Product Portfolio
  - 16.3.1.3. Financial Overview
  - 16.3.1.4. SWOT Analysis
  - 16.3.1.5. Strategic Overview
- 16.3.2. Nestle S.A.
  - 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 16.3.2.2. Product Portfolio
  - 16.3.2.3. Financial Overview
  - 16.3.2.4. SWOT Analysis
  - 16.3.2.5. Strategic Overview
- 16.3.3. Abbott Laboratories
  - 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 16.3.3.2. Product Portfolio
  - 16.3.3.3. Financial Overview
  - 16.3.3.4. SWOT Analysis
  - 16.3.3.5. Strategic Overview
- 16.3.4. Mead Johnson Nutrition
  - 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 16.3.4.2. Product Portfolio
  - 16.3.4.3. Financial Overview
  - 16.3.4.4. SWOT Analysis
  - 16.3.4.5. Strategic Overview
- 16.3.5. Fresenius Kabi
  - 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 16.3.5.2. Product Portfolio
  - 16.3.5.3. Financial Overview
  - 16.3.5.4. SWOT Analysis
  - 16.3.5.5. Strategic Overview
- 16.3.6. Friso
  - 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 16.3.6.2. Product Portfolio
  - 16.3.6.3. Financial Overview
  - 16.3.6.4. SWOT Analysis
  - 16.3.6.5. Strategic Overview
- 16.3.7. Morinaga Milk Industry
  - 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 16.3.7.2. Product Portfolio
  - 16.3.7.3. Financial Overview
  - 16.3.7.4. SWOT Analysis
  - 16.3.7.5. Strategic Overview
- 16.3.8. Primus Pharmaceuticals, Inc.
  - 16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 16.3.8.2. Product Portfolio
  - 16.3.8.3. Financial Overview
  - 16.3.8.4. SWOT Analysis
  - 16.3.8.5. Strategic Overview
- 16.3.9. Targeted Medical Pharma, Inc.
  - 16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 16.3.9.2. Product Portfolio
  - 16.3.9.3. Financial Overview
  - 16.3.9.4. SWOT Analysis
  - 16.3.9.5. Strategic Overview
- 16.3.10. Medtrition, Inc.
  - 16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 16.3.10.2. Product Portfolio
  - 16.3.10.3. Financial Overview
  - 16.3.10.4. SWOT Analysis
  - 16.3.10.5. Strategic Overview

医療用食品市場（製品タイプ：錠剤、粉末、液体、その他、投与経路：経口、経腸）-世界の産業分析、規模、シェア、成長、動向、予測、2023年-2031年

Medical Foods Market (Product Type: Pills, Powder, Liquid, and Others; Route of Administration: Oral and Enteral) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

医療用食品市場- 調査範囲：

目次

第1章 序文

第2章 前提条件と調査手法

第3章 エグゼクティブサマリー：世界市場

第4章 市場の概要

第5章 主要な洞察

第6章 世界市場分析・予測：製品タイプ別

第7章 世界市場分析・予測：疾患タイプ別

第8章 世界市場分析・予測：投与経路別

第9章 世界市場分析・予測：流通チャネル別

第10章 世界市場分析・予測：地域別

第11章 北米市場の分析・予測

第12章 欧州市場の分析と予測

第13章 アジア太平洋地域の市場分析と予測

第14章 ラテンアメリカの市場分析・予測

第15章 中東・アフリカ市場の分析と予測

第16章 競合情勢